TECH Bio-Techne
Nasdaq · SEC CIK 842023 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $437.2K 2 sales by 1 insiders
- Filings on record
- 188 since 2021-07-14, latest 2026-09-24 16:52
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Herr Amy E. | Dir | — | $437.2K |
| Crouse Steven C. | Pres - Diag, Spatial Bi | — | — |
| Bohnen Shane | SVP - GC | — | — |
| McManus Matthew | Pres - Diag, Spatial Bio | — | — |
| Geist William | Pres, PROTEIN SCIENCES | — | — |
| Klimovsky Judith V. | Dir | — | — |
| Kelderman Kim | CEO, Dir | — | — |
| Seth Alpna | Dir | — | — |
| Vessey Rupert | Dir | — | — |
| Hippel James | CFO | — | — |
Transactions 246
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-16 | 2021-11-12+ | TECH | Eansor Norman David | Pres-Protein Sciences | M - OptEx | $125.05 | +28.0K | 28.5K | +5,387% | +$3.50M |
| DM | 2021-11-03 | 2021-11-01+ | TECH | Hippel James | CFO | M - OptEx | $125.05 | +9,022 | 19.6K | +85% | +$1.13M |
| DM | 2021-11-03 | 2021-11-01+ | TECH | Hippel James | CFO | S - Sale+OE | $526.49 | -9,022 | 16.0K | -36% | -$4.75M |
| D | 2021-11-01 | 2021-10-28 | TECH | Nusse Roeland | Dir | A - Grant | $0.00 | +194 | 6,959 | +3% | $0 |
| D | 2021-11-01 | 2021-10-28 | TECH | Seth Alpna | Dir | A - Grant | $0.00 | +194 | 2,333 | +9% | $0 |
| DM | 2021-11-01 | 2021-10-28+ | TECH | Hippel James | CFO | S - Sale+OE | $525.22 | -762 | 10.8K | -7% | -$400.2K |
| D | 2021-11-01 | 2021-10-29 | TECH | Hippel James | CFO | M - OptEx | $125.05 | +662 | 11.4K | +6% | +$82.8K |
| D | 2021-11-01 | 2021-10-28 | TECH | BAUMGARTNER ROBERT V | Dir | A - Grant | $0.00 | +194 | 9,806 | +2% | $0 |
| D | 2021-11-01 | 2021-10-28 | TECH | KEEGAN JOSEPH D | Dir | A - Grant | $0.00 | +194 | 2,333 | +9% | $0 |
| D | 2021-11-01 | 2021-10-28 | TECH | STEER RANDOLPH C | Dir | A - Grant | $0.00 | +194 | 5,306 | +4% | $0 |
| D | 2021-11-01 | 2021-10-28 | TECH | HIGGINS JOHN L | Dir | A - Grant | $0.00 | +194 | 4,606 | +4% | $0 |
| D | 2021-11-01 | 2021-10-28 | TECH | VESSEY RUPERT | Dir | A - Grant | $0.00 | +194 | 1,227 | +19% | $0 |
| D | 2021-11-01 | 2021-10-28 | TECH | Bushman Julie L | Dir | A - Grant | $0.00 | +194 | 674 | +40% | $0 |
| 2021-09-24 | 2021-09-22 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | S - Sale | $529.04 | -822 | 0 | -100% | -$434.9K | |
| DM | 2021-09-09 | 2021-09-07 | TECH | STEER RANDOLPH C | Dir | M - OptEx | $89.58 | +8,000 | 13.1K | +156% | +$716.7K |
| DM | 2021-09-09 | 2021-09-07 | TECH | STEER RANDOLPH C | Dir | S - Sale+OE | $509.98 | -8,000 | 10.2K | -44% | -$4.08M |
| D | 2021-09-07 | 2021-09-02 | TECH | Furlow Brenda S. | SVP - GC | M - OptEx | $125.05 | +6,871 | 14.5K | +90% | +$859.2K |
| DM | 2021-09-07 | 2021-09-02 | TECH | Furlow Brenda S. | SVP - GC | S - Sale+OE | $509.93 | -6,871 | 9,196 | -43% | -$3.50M |
| D | 2021-09-07 | 2021-09-02 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $108.49 | +73.5K | 238.6K | +45% | +$7.97M |
| D | 2021-09-07 | 2021-09-02 | TECH | Kummeth Charles R. | CEO, Dir | F - Tax | $510.78 | -42.0K | 196.6K | -18% | -$21.46M |
| DM | 2021-09-07 | 2021-09-02 | TECH | Hippel James | CFO | S - Sale+OE | $507.22 | -10.0K | 10.9K | -48% | -$5.07M |
| D | 2021-09-07 | 2021-09-02 | TECH | Hippel James | CFO | M - OptEx | $106.59 | +10.0K | 20.9K | +92% | +$1.07M |
| 2021-09-02 | 2021-08-31 | TECH | Eansor Norman David | Pres-Protein Sciences | S - Sale | $503.07 | -1,538 | 1,318 | -54% | -$773.7K | |
| D | 2021-09-02 | 2021-08-31 | TECH | Furlow Brenda S. | SVP - GC | M - OptEx | $125.05 | +5,000 | 12.6K | +66% | +$625.2K |
| DM | 2021-09-02 | 2021-08-31 | TECH | Furlow Brenda S. | SVP - GC | S - Sale+OE | $505.66 | -5,000 | 7,620 | -40% | -$2.53M |
| DM | 2021-08-25 | 2021-08-23 | TECH | BAUMGARTNER ROBERT V | Dir | S - Sale+OE | $485.54 | -4,000 | 9,612 | -29% | -$1.94M |
| D | 2021-08-25 | 2021-08-23 | TECH | BAUMGARTNER ROBERT V | Dir | M - OptEx | $87.39 | +4,000 | 13.6K | +42% | +$349.6K |
| D | 2021-08-25 | 2021-08-23 | TECH | Nusse Roeland | Dir | S - Sale+OE | $481.52 | -4,000 | 6,765 | -37% | -$1.93M |
| D | 2021-08-25 | 2021-08-23 | TECH | Nusse Roeland | Dir | M - OptEx | $70.35 | +4,000 | 10.8K | +59% | +$281.4K |
| DM | 2021-08-23 | 2021-08-19 | TECH | Furlow Brenda S. | SVP - GC | S - Sale+OE | $473.95 | -3,538 | 10.1K | -26% | -$1.68M |
| DM | 2021-08-23 | 2021-08-19 | TECH | Furlow Brenda S. | SVP - GC | M - OptEx | $109.99 | +4,337 | 11.2K | +64% | +$477.0K |
| D | 2021-08-13 | 2021-08-11 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $108.49 | +921 | 165.1K | +0.6% | +$99.9K |
| DM | 2021-08-10 | 2021-08-09 | TECH | Hippel James | CFO | S - Sale+OE | $478.90 | -10.0K | 10.9K | -48% | -$4.79M |
| D | 2021-08-10 | 2021-08-08 | TECH | Hippel James | CFO | F - Tax | $481.82 | -1,665 | 10.9K | -13% | -$802.2K |
| DM | 2021-08-10 | 2021-08-08+ | TECH | Hippel James | CFO | M - OptEx | $79.65 | +13.4K | 12.5K | New | +$1.07M |
| D | 2021-08-10 | 2021-08-06 | TECH | Kummeth Charles R. | CEO, Dir | A - Grant | $0.00 | +5,344 | 159.8K | +3% | $0 |
| D | 2021-08-10 | 2021-08-06 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $0.00 | +16.9K | 176.7K | +11% | $0 |
| D | 2021-08-10 | 2021-08-06 | TECH | Kummeth Charles R. | CEO, Dir | F - Tax | $481.82 | -12.5K | 164.2K | -7% | -$6.01M |
| D | 2021-08-10 | 2021-08-08 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | F - Tax | $481.82 | -869 | 822 | -51% | -$418.7K |
| D | 2021-08-10 | 2021-08-08 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $0.00 | +1,691 | 1,691 | New | $0 |
| D | 2021-08-10 | 2021-08-08 | TECH | Furlow Brenda S. | SVP - GC | F - Tax | $481.82 | -677 | 6,821 | -9% | -$326.2K |
| D | 2021-08-10 | 2021-08-08 | TECH | Furlow Brenda S. | SVP - GC | M - OptEx | $0.00 | +1,374 | 7,498 | +22% | $0 |
| D | 2021-08-10 | 2021-08-08 | TECH | Eansor Norman David | Pres-Protein Sciences | M - OptEx | $0.00 | +2,537 | 3,855 | +192% | $0 |
| D | 2021-08-10 | 2021-08-08 | TECH | Eansor Norman David | Pres-Protein Sciences | F - Tax | $481.82 | -999 | 2,856 | -26% | -$481.3K |
| D | 2021-07-14 | 2021-07-12 | TECH | Hippel James | CFO | M - OptEx | $106.59 | +10.0K | 19.1K | +109% | +$1.07M |
| DM | 2021-07-14 | 2021-07-12 | TECH | Hippel James | CFO | S - Sale+OE | $456.67 | -10.0K | 14.0K | -42% | -$4.57M |
Purchase Sale Sale after option exercise All abbreviations